BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

744 related articles for article (PubMed ID: 10950059)

  • 41. Periodic health examination, 1994 update: 2. Screening strategies for colorectal cancer. Canadian Task Force on the Periodic Health Examination.
    Solomon MJ; McLeod RS
    CMAJ; 1994 Jun; 150(12):1961-70. PubMed ID: 7980760
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Family history and colorectal cancer screening: a survey of physician knowledge and practice patterns.
    Schroy PC; Barrison AF; Ling BS; Wilson S; Geller AC
    Am J Gastroenterol; 2002 Apr; 97(4):1031-6. PubMed ID: 12008667
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of colonoscopy for colorectal cancer screening: evidence from the 2000 National Health Interview Survey.
    Subramanian S; Amonkar MM; Hunt TL
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):409-16. PubMed ID: 15734966
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Test-retest reliability of colorectal testing questions on the Massachusetts Behavioral Risk Factor Surveillance System (BRFSS).
    Bradbury BD; Brooks DR; Brawarsky P; Mucci LA
    Prev Med; 2005 Jul; 41(1):303-11. PubMed ID: 15917026
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increase in screening for colorectal cancer in older Americans: results from a national survey.
    Chen X; White MC; Peipins LA; Seeff LC
    J Am Geriatr Soc; 2008 Aug; 56(8):1511-6. PubMed ID: 18662217
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
    Inadomi JM
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictors of colorectal cancer screening participation in the United States.
    Ioannou GN; Chapko MK; Dominitz JA
    Am J Gastroenterol; 2003 Sep; 98(9):2082-91. PubMed ID: 14499792
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Screening for colorectal cancer on the front line.
    Lemon SC; Zapka JG; Estabrook B; Erban S; Luckmann R
    Am J Gastroenterol; 2003 Apr; 98(4):915-23. PubMed ID: 12738477
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low uptake of colorectal cancer screening 3 yr after release of national recommendations for screening.
    McGregor SE; Hilsden RJ; Li FX; Bryant HE; Murray A
    Am J Gastroenterol; 2007 Aug; 102(8):1727-35. PubMed ID: 17437502
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Colorectal cancer screening and surveillance.
    Harford WV
    Surg Oncol Clin N Am; 2006 Jan; 15(1):1-20, v. PubMed ID: 16389147
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recommendations on population screening for colorectal cancer in New Zealand. Members of the National Health Committee Working Party on Population Screening for Colorectal Cancer.
    N Z Med J; 1999 Jan; 112(1080):4-6. PubMed ID: 10073156
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Colorectal cancer: a summary of the evidence for screening and prevention.
    Wilkins T; Reynolds PL
    Am Fam Physician; 2008 Dec; 78(12):1385-92. PubMed ID: 19119558
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Colorectal cancer screening programs in the population at average risk in the European Union and Spain].
    Grau J; Serradesanferm A; Polbach S; GarcĂ­a-Basteiro AL; Trilla A; Castells A
    Gastroenterol Hepatol; 2010 Feb; 33(2):111-8. PubMed ID: 19523716
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Persistent demographic differences in colorectal cancer screening utilization despite Medicare reimbursement.
    Ko CW; Kreuter W; Baldwin LM
    BMC Gastroenterol; 2005 Mar; 5():10. PubMed ID: 15755323
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Colorectal cancer screening: an overview of available methods and current recommendations.
    Early DS
    South Med J; 1999 Mar; 92(3):258-65. PubMed ID: 10094264
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Validity of self-reported colorectal cancer screening behavior.
    Baier M; Calonge N; Cutter G; McClatchey M; Schoentgen S; Hines S; Marcus A; Ahnen D
    Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):229-32. PubMed ID: 10698488
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Colonoscopic evaluation of immunochemical fecal occult blood test for detection of colorectal neoplasia.
    Nakama H; Yamamoto M; Kamijo N; Li T; Wei N; Fattah AS; Zhang B
    Hepatogastroenterology; 1999; 46(25):228-31. PubMed ID: 10228797
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Screening for colorectal cancer. A comparison of 3 fecal occult blood tests.
    Levin B; Hess K; Johnson C
    Arch Intern Med; 1997 May; 157(9):970-6. PubMed ID: 9140267
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Accuracy of immunological fecal occult blood testing for colorectal cancer screening.
    Nakama H; Kamijo N
    Prev Med; 1994 May; 23(3):309-13. PubMed ID: 8078851
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Screening for colorectal cancer and polyps].
    Krieger Y; Fraser D; Odes HS; Krugliak P; Fraser GM
    Harefuah; 1992 Mar; 122(6):354-6, 408. PubMed ID: 1582622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.